Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tong Ren Tang Shilintong Granules is a traditional Chinese medicine (TCM) formulated as granules, primarily developed and manufactured by Beijing Tong Ren Tang. The sole active ingredient is the extract of *Desmodium styracifolium* (Guang Jin Qian Cao / Coin-leaved Desmodium). It is traditionally used to clear damp-heat, promote diuresis, and expel urinary calculi. Its primary indications include urinary tract stones (urolithiasis), pyelonephritis, and cholecystitis. The herbal extract works through multiple mechanisms, including promoting urination to help flush out stones, exerting anti-inflammatory and anti-infective effects in the urinary tract, and relaxing smooth muscles to ease the passage of calculi.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tong Ren Tang Shilintong Granules.